Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection - review
AUTOR(ES)
Nicol, Alcina Frederica, Fernandes, Ana Teresa Gomes, Bonecini-Almeida, Maria da Gloria
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2005-02
RESUMO
Human immunodeficiency virus (HIV-1) has become an important risk factor for human papillomavirus (HPV) infection and the development of HPV associated lesions in the female genital tract. HIV-1 may also increase the oncogenicity of high risk HPV types and the activation of low risk types. The Center for Disease Control and Prevention declared invasive cervical cancer an acquired immunodeficience virus (AIDS) defining illness in HIV positive women. Furthermore, cervical cancer happens to be the second most common female cancer worldwide. The host's local immune response plays a critical factor in controlling these conditions, as well as in changes in the number of professional antigen-presenting cells, cytokine, and MHC molecules expression. Also, the production of cytokines may determine which arm of the immune response will be stimulated and may influence the magnitude of immune protection. Although there are many studies describing the inflammatory response in HPV infection, few data are available to demonstrate the influence of the HIV infection and several questions regarding the cervical immune response are still unknown. In this review we present a brief account of the current understanding of HIV/HPV co-infection, emphasizing cervical immune response.
Documentos Relacionados
- JC virus/human immunodeficiency virus 1 co-infection in the Brazilian Amazonian region
- Prevalence of human immunodeficiency virus/hepatitis C virus co-infection in Brazil and associated factors: a review
- Co-infection with hepatitis C virus and human T lymphocyte virus
- Human immunodeficiency virus and hepatitis C virus/hepatitis B virus co-infection in Southern Brazil: clinical and epidemiological evaluation
- Low prevalence of human immunodeficiency virus and hepatitis C virus co-infection in a medium size city in southern Brazil